https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20200203-33
1.Scrip code : 541444
Name : Palm Jewels Limited
Subject : Board Meeting Intimation for Intimation To Convene Board Meeting
Palm Jewels Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2020 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 10, 2020 at 05.00 P.M at Registered Office of the company to inter-alia, to consider and transact the following business: 1. To consider increase in Authorised share capital of company and alteration of clause V of memorandum of association of company pursuant to increase in authorised share capital. 2. To consider the issue of Bonus Share.
2.Scrip code : 539524
Name : Dr. Lal Pathlabs Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations), we wish to inform you that the Board of Directors in their meeting held today, i.e. February 3, 2020, approved the Scheme of Amalgamation between APL Institute of Clinical Laboratory & Research Private Limited (‘the Transferor Company’), a wholly owned subsidiary of the Company and Dr. Lal PathLabs Limited (‘the Company/the Transferee Company’) with effect from April 1, 2020 (‘Appointed Date’), pursuant to Sections 230-232 of the Companies Act, 2013.
3.Scrip code : 532859
Name : Hinduja Global Solutions Limited
Subject : Announcement under Regulation 30 (LODR)-Updates on Acquisition
HGS International Mauritius, (a wholly owned subsidiary of Hinduja Global Solutions Limited) which, holds 95.2% equity interest in ‘HGS Colibrium Inc., USA’ has acquired an additional equity interest of 4.8% in ‘HGS Colibrium Inc., USA’. Consequently, the shareholding of the HGS International, Mauritius in HGS Colibrium Inc., has increased to 100%. As required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015, dated September 9, 2015, we submit the details of the proposed acquisition in the enclosed SEBI’s Prescribed format.
